AlphaYouMT
Insider selling
Michael Thomas Heffernan sold $596K of Trevi Therapeutics, Inc. (TRVI) stock
Michael Thomas Heffernan, Dir of Trevi Therapeutics, Inc. (TRVI), sold 39,473 shares of TRVI stock worth $596K, per an SEC Form 4 filed Sep 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 15, 2026, 2 days before it was made public.
TRVI has moved -3.9% since the trade date, from $15.04 to $14.46 (Sep 23, 2026 close).
- Traded
- Sep 15, 2026
- Disclosed
- Sep 17, 2026
- Filing delay
- 2 days
- Price since
- -3.9%
- Role
- Dir
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.